Additional studies demonstrating nuclear activity of LOX focused on its’ tumor-suppressor properties in the ras-transformed cells, RS485 (NIH 3T3 transformed by c-H-ras), cells which normally express low LOX levels [43,44,45,46]. This evidence concerns the gene LOX and neoplasm.